BACIL PHARMA LTD. SHARE PRICE [LIVE]

BSE: INE711D01018   NSE: BACPHAR   SECTOR: Trading

OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
N/A
Change:
BSE
6.85
Change:
NSE
BSE Click here to view BSE data
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality
Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
Sector
Sensex
Name Mar 21 Dec 20

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in BACIL PHARMA LTD.

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

BACPHAR News

Frequently Asked Questions

What is the Share price of BACIL PHARMA LTD. (BACPHAR)?

BACIL PHARMA LTD. (BACPHAR) share price as of August 12, 2022, on BSE is Rs 6.85 (BSE).

Can I buy BACIL PHARMA LTD. (BACPHAR) shares?

Yes, You can buy BACIL PHARMA LTD. (BACPHAR) shares by opening a Demat account with Angel One.

How do I buy BACIL PHARMA LTD. (BACPHAR) from Angel One?

BACIL PHARMA LTD. (BACPHAR) share can be brought through the following modes:
  1. Direct investment: You can buy BACIL PHARMA LTD. (BACPHAR) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to BACIL PHARMA LTD. (BACPHAR) shares.

In which sector do BACIL PHARMA LTD. (BACPHAR) belong?

BACIL PHARMA LTD. (BACPHAR) belongs to Trading.

About BACPHAR

Today's live share price for BACIL PHARMA LTD. is NSE: N/A, BSE: ₹ 6.85 with a current market capitalization of .

Incorporated as a private limited company in Maharashtra in May '87, Bacil Pharma (BPL) was converted into a public limited company in Oct.'90. BPL came out with a public issue of Rs 7 cr in Mar.'94 to set up a plant at Vapi to manufacture bulk drugs like atenalol, norfloxacin, pefloxacin and ciprofloxacin. The comapany entered into a marketing arrangement with a distributor Kam Han Industries, Hong Kong, to export 50% of the production. Due to various reasons, the civil works at Vapi were affected. However, to avoid further delay in project implementation, the company acquired from SICOM an existing bulk drug unit with necessary infrastructure and production facilities at Lote Parashuram (near Ratnagiri).

Read more